Sign in
Taking people in South KoreaNo phase

Studying gut bacteria in people with chronic liver disease

Looks at gut bacteria in people with long-lasting liver disease to learn how it develops.

Key facts

Who runs it
Chungnam National University Hospital
Where
Daejeon, South KoreaSee the site
Trial code
Registry title
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Status
Recruiting
People taking part
3,000 people, planned
Started
8 Jul 2024
Expected to end
8 Jul 2029
Type of study
Observational
Record updated
20 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease or liver abscess. People who live with such a patient can also join.

Age
19 years and older
Sex
Women and men can join.

Main reasons for not taking part

  • People under 19 years of age
  • Patients or guardians who do not consent to take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital
  • Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital
  • Exclusion

Who cannot take part

  • Individuals under the age of 19
  • Patients or guardians who do not consent to participate in the study

This trial is currently available in South Korea.

  • Chungnam National University HospitaDaejeon, South KoreaContact: HyukSoo EunTaking people

About the trial

What the trial wants to find out

In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
Plain-language title
Studying gut bacteria in people with chronic liver diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
20 March 2026